Golf stud, At this point there could be a number of reasons why Denner may be
compelled NOT to purchase any more shares. If that turns out to be the case,
let's hope it is for a good reason. So long as Denner retains his current stake,
we have a valid reason to keep our shares. (I only hope Denner does not ditch his
position or that management initiates a reverse split.) I have little faith in KM
as he was supposed be the expert on Europe reimbursement negotiations.
So far, I have not been impressed by anything he has done. I wish there was
at least some additional color on China. I thought it had been approved in
Hong-Kong. If so, I'd lie to know how it is being sold there, that is, if it is being
sold at all. I'm holding until BO or bankruptcy. I do believe that it is obvious to
all that a BP BO is the only way to optimize uptake and revenues of Vascepa.